| U.S. Federal Trade Commission |
FTC News Release, Jun 24, 2004
Claims That “Biotape” Relieves Severe Pain Challenged by the FTC
Defendants Allegedly Do Not Have Adequate Evidence to Support the Claims
The Federal Trade Commission has charged
that Smart Inventions, Inc., a California-based direct
response TV company, and its Chief Operating Officer, Jon D.
Nokes, made false and unsubstantiated claims that a product
called “Biotape” can treat or cure severe pain. The FTC
complaint, filed in the Central District of California, also
alleges that the defendants falsely claimed Biotape is
superior to commonly available over-the-counter analgesics and
topical creams and ointments in treating pain. The defendants
advertised Biotape, which resembles electrical tape, primarily
through a 30-minute infomercial that aired nationally on
various cable stations, including Women’s Entertainment, The
Discovery Channel, and the Inspirational Network. Darrell
Stoddard - who developed Biotape and is featured in the
infomercial along with the infomercial host Kevin Trudeau -
also is named as a defendant.
The infomercial sold Biotape in conjunction
with Stoddard’s book, “Pain Free for Life.” A sheet of 10
adhesive Biotape strips costs approximately $10. The
infomercial directed consumers to apply Biotape to the parts
of their bodies where they experience pain. Biotape was
purported to contain a “space age conductive mylar that
connects the broken circuits that cause the pain.” The FTC
complaint alleges that the defendants have falsely and without
substantiation claimed that Biotape: (1) significantly and
permanently relieves severe pain caused by surgical
procedures, arthritis, migraines, and other serious
conditions; and (2) is superior to other products and
treatments, such as over-the-counter analgesics and topical
creams and ointments, in eliminating or relieving severe
pain.
In a separate action filed by the Commission
in June 2003, the FTC previously sued Trudeau for his role
in making false or unsubstantiated pain-relief claims in the
Biotape infomercial, charging that such claims violated a 1998
federal district court order. This contempt action against
Trudeau is pending in the U.S. District Court for the Northern
District of Illinois.
The Commission vote to authorize
staff to file the complaint was 5-0. The complaint
was filed in the U.S. District Court, Central District of
California, on June 18, 2004.
The text in this article was prepared by the U.S. Federal Trade Commission.